Results 131 to 140 of about 82,470 (284)

First Description of Atypical Aspergillus floccosus as Cause of Canine Systemic Aspergillosis With Discospondylitis

open access: yesVeterinary Medicine and Science, Volume 11, Issue 4, July 2025.
A case of disseminated aspergillosis in dog was described due to an atypical strain of Aspergillus floccosus. Aspergillosis should be considered in the differential diagnosis of dogs with neurological signs and nonspecific changes in CBC or CMP, particularly in German Shepherd dogs.
Talita Bordoni   +6 more
wiley   +1 more source

Evans Medicine [PDF]

open access: yes, 1989
Newsletter of the Evans Memorial Department of Clinical Research and Preventive Medicine at University ...
Levinsky, Norman G.   +1 more
core  

Phage‐Antibiotic Combinations for Pseudomonas: Successes in the Clinic and In Vitro Tenuously Connected

open access: yesMicrobial Biotechnology, Volume 18, Issue 7, July 2025.
Phage antibiotic combinations have proven particularly successful against Pseudomonas in the clinic (right) and in the lab (left), but the connections between the two are tenuous. Here, we explore the mechanisms and measurements of the latter and highlight which are likely ill‐suited to treatment success.
Rabia Fatima, Alexander P. Hynes
wiley   +1 more source

Fluconazole prophylaxis in preterm infants: a systematic review

open access: yesBrazilian Journal of Infectious Diseases, 2017
Objective: This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis.
Juliana Ferreira da Silva Rios   +3 more
doaj  

Effect of Rifampicin on the Pharmacokinetics of Valemetostat and Its Primary Metabolite: A Phase 1 Study in Healthy Participants

open access: yesClinical and Translational Science, Volume 18, Issue 7, July 2025.
ABSTRACT Valemetostat tosylate (valemetostat) is a dual inhibitor of enhancer of zeste homolog (EZH)2 and EZH1, approved in Japan for the treatment of relapsed or refractory peripheral T‐cell lymphoma, including adult T‐cell leukemia/lymphoma, and globally under investigation for the treatment of non‐Hodgkin lymphomas and solid tumors.
Masaya Tachibana   +5 more
wiley   +1 more source

Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro [PDF]

open access: green, 1994
Michael R. Yeaman   +5 more
openalex   +1 more source

Involvement of People Living with HIV/AIDS in Treatment Preparedness in Thailand [PDF]

open access: yes, 2004
Perspective and Practice in Antiretroviral Treatment: Case ...
Kumphitak, A   +4 more
core   +1 more source

A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 7, Page 3598-3606, July 2025.
Abstract The development of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors represents a major turning point in the effort to preserve kidney function and prevent cardiovascular events and heart failure hospitalisations in those at high risk. These agents have now transcended their original glucose‐lowering indication and provide a range of clinical
Daniel Vincent O'Hara, Meg J. Jardine
wiley   +1 more source

Fluconazole in neonatal disseminated candidiasis. [PDF]

open access: bronze, 1991
Dawn Wiest   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy